Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity.
ELISpot assay
SARS-CoV-2
T cell immunity
cytokines
granzyme B
immune modeling
Journal
Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724
Informations de publication
Date de publication:
13 07 2022
13 07 2022
Historique:
pubmed:
15
6
2022
medline:
26
7
2022
entrez:
14
6
2022
Statut:
ppublish
Résumé
Cell-mediated immunity is critical for long-term protection against most viral infections, including coronaviruses. We studied 23 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected survivors over a 1-year post-symptom onset (PSO) interval by
Identifiants
pubmed: 35699447
doi: 10.1128/jvi.00509-22
pmc: PMC9278147
doi:
Substances chimiques
COVID-19 Vaccines
0
Cytokines
0
Interleukin-2
0
spike protein, SARS-CoV-2
0
Interferon-gamma
82115-62-6
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0050922Subventions
Organisme : Gouvernement du Canada | Canadian Institutes of Health Research (IRSC)
ID : VR1-172711
Commentaires et corrections
Type : ErratumIn